|
HU177419B
(en)
*
|
1978-07-13 |
1981-10-28 |
Chinoin Gyogyszer Es Vegyeszet |
Process for preparing threedimensional,retentive polymers consisting of cyclodextrin and polyvinylalcohol units,capable of forming inclusion complexes in the form of bead,fibre or mainly block
|
|
EP0013688B1
(en)
*
|
1978-12-15 |
1984-02-01 |
Kyoshin Co., Ltd. |
A perfumed synthetic resin product and a method of producing said product
|
|
JPS609524B2
(ja)
*
|
1979-06-01 |
1985-03-11 |
理化学研究所 |
シクロデキストリンの回収法
|
|
HU184066B
(en)
*
|
1979-12-28 |
1984-06-28 |
Chinoin Gyogyszer Es Vegyeszet |
Plant growth regulating substance and process for preparing such compound
|
|
HU181733B
(en)
*
|
1980-08-07 |
1983-11-28 |
Chinoin Gyogyszer Es Vegyeszet |
Process for preparing sorbents containing cyclodextrin on cellulose base
|
|
JPS57130914A
(en)
*
|
1981-02-04 |
1982-08-13 |
Agency Of Ind Science & Technol |
Prolongation of activity retention
|
|
HU189534B
(en)
*
|
1981-09-09 |
1986-07-28 |
Chinoin Rt.,Hu |
Process for producing new tablets containing cyclodextrin polymer as desintegrator
|
|
HU191101B
(en)
*
|
1983-02-14 |
1987-01-28 |
Chinoin Gyogyszer Es Vegyeszeti Termekek Gyara Rt,Hu |
Process for preparing water-soluble cyclodextrin polymers substituted with ionic groups
|
|
JPS6081166A
(ja)
*
|
1983-10-11 |
1985-05-09 |
Fujisawa Pharmaceut Co Ltd |
2−ニトロオキシメチル−6−クロロピリジンのβ−シクロデキストリン包接化合物およびその製造法
|
|
JPS60202115A
(ja)
*
|
1984-03-27 |
1985-10-12 |
Ichiro Shibauchi |
エポキシ樹脂用硬化剤
|
|
US4727064A
(en)
*
|
1984-04-25 |
1988-02-23 |
The United States Of America As Represented By The Department Of Health And Human Services |
Pharmaceutical preparations containing cyclodextrin derivatives
|
|
US4596795A
(en)
*
|
1984-04-25 |
1986-06-24 |
The United States Of America As Represented By The Secretary, Dept. Of Health & Human Services |
Administration of sex hormones in the form of hydrophilic cyclodextrin derivatives
|
|
JPS61152765A
(ja)
*
|
1984-12-27 |
1986-07-11 |
Nippon Ekishiyou Kk |
シクロデキストリン類で包接された化合物を含有した合成樹脂製品及びその製造方法
|
|
US4769474A
(en)
*
|
1985-04-10 |
1988-09-06 |
Mitsui Toatsu Chemicals, Inc. |
Process for purifying tryptophane
|
|
SE452469B
(sv)
*
|
1986-06-18 |
1987-11-30 |
Pharmacia Ab |
Material bestaende av en tverbunden karboxylgrupphaltig polysackarid och forfarande vid framstellning av detsamma
|
|
US4897472A
(en)
*
|
1986-11-19 |
1990-01-30 |
Oy Alko Ab |
Process for isolation and purification of cyclodextrins
|
|
US4808232A
(en)
*
|
1986-12-08 |
1989-02-28 |
American Maize-Products Company |
Separation and purification of cyclodextrins
|
|
US5273820A
(en)
*
|
1986-12-08 |
1993-12-28 |
American Maize-Products Company |
Separation and purification of cyclodextrins
|
|
US4898921A
(en)
*
|
1987-06-03 |
1990-02-06 |
Montclair State College |
Conducting polymer films, method of manufacture and applications therefor
|
|
US5658894A
(en)
*
|
1989-04-23 |
1997-08-19 |
The Trustees Of The University Of Pennsylvania |
Compositions for inhibiting restenosis
|
|
US5637575A
(en)
*
|
1988-01-19 |
1997-06-10 |
The Trustees Of The University Of Pennsylvania |
Methods of inhibiting restenosis
|
|
US5760015A
(en)
*
|
1988-01-19 |
1998-06-02 |
The Trustees Of The University Of Pennsylvania |
Cyclodextrin compounds and methods of making and use thereof
|
|
JPH0269540A
(ja)
*
|
1988-09-05 |
1990-03-08 |
Chisso Corp |
結晶性ポリオレフイン組成物
|
|
US5441944A
(en)
*
|
1989-04-23 |
1995-08-15 |
The Trustees Of The University Of Pennsylvania |
Substituted cyclodextrin sulfates and their uses as growth modulating agents
|
|
US5075432A
(en)
*
|
1989-08-11 |
1991-12-24 |
Edward Vanzo |
Spherical cyclodextrin polymer beads
|
|
IT1255981B
(it)
*
|
1991-04-30 |
1995-11-17 |
Ministero Dell Uni E Della |
Composizione adesiva a piu' componenti
|
|
US5446030A
(en)
*
|
1991-09-19 |
1995-08-29 |
Weisz; Paul B. |
Prevention of hemolysis
|
|
AU6553994A
(en)
*
|
1993-03-31 |
1994-10-24 |
Trustees Of The University Of Pennsylvania, The |
Methods of affecting the growth of living tissue in mammals and compounds and compositions therefor
|
|
US5492947A
(en)
*
|
1994-06-23 |
1996-02-20 |
Aspen Research Corporation |
Barrier material comprising a thermoplastic and a compatible cyclodextrin derivative
|
|
US6048736A
(en)
*
|
1998-04-29 |
2000-04-11 |
Kosak; Kenneth M. |
Cyclodextrin polymers for carrying and releasing drugs
|
|
WO2004064816A1
(en)
*
|
2003-01-16 |
2004-08-05 |
Cornell Research Foundation, Inc. |
PARTIALLY BIODEGRADABLE TEMPERATURE AND pH SENSITIVE HYDROGEL
|
|
EP2336317B1
(en)
|
2003-06-13 |
2019-09-11 |
Alnylam Europe AG |
Double-stranded ribonucleic acid with increased effectiveness in an organism
|
|
PT1691811E
(pt)
|
2003-12-11 |
2014-10-30 |
Sunovion Pharmaceuticals Inc |
Combinação de um sedativo e de um modulador de neurotransmissores e métodos para melhorar a qualidade do sono e tratamento da depressão
|
|
US7632485B2
(en)
|
2004-02-24 |
2009-12-15 |
Massachusetts General Hospital |
Catalytic radiofluorination
|
|
EP3034510A1
(en)
|
2004-04-30 |
2016-06-22 |
Alnylam Pharmaceuticals Inc. |
Oligonucleotides comprising a c5-modified pyrimidine
|
|
EP1768966B1
(en)
|
2004-06-17 |
2012-03-07 |
Infinity Discovery, Inc. |
Coumpounds and methods for inhibiting the interaction of bcl proteins with binding partners
|
|
MX2007010144A
(es)
*
|
2005-02-18 |
2008-02-15 |
Surface Logix Inc |
Compuestos mejorados farmacocineticamente.
|
|
SG174829A1
(en)
*
|
2005-02-18 |
2011-10-28 |
Surface Logix Inc |
Methods of making pharmacokinetically improved compounds comprising functional residues or groups and pharmaceutical compositions comprising said compounds
|
|
ES2310948B2
(es)
*
|
2005-02-25 |
2009-09-16 |
Universidade De Santiago De Compostela |
Procedimiento de obtencion de hidrogeles de ciclodextrinas con glicidileteres, las composiciones obtenidas y sus aplicaciones.
|
|
US8669236B2
(en)
*
|
2005-05-12 |
2014-03-11 |
The General Hospital Corporation |
Biotinylated compositions
|
|
MX2009001279A
(es)
|
2006-08-03 |
2009-02-11 |
Tufts College |
Analogos de niacina no eritematosos, y metodos para utilizar los mismos.
|
|
KR100785913B1
(ko)
*
|
2006-11-29 |
2007-12-17 |
한국과학기술연구원 |
경화된 β-사이클로덱스트린 중합체 분말과 그의 제조방법
|
|
WO2009013770A1
(en)
*
|
2007-07-26 |
2009-01-29 |
Humanitas Mirasole S.P.A. |
Derivatised polysaccharide material for the transdermal administration of drugs
|
|
WO2009032199A1
(en)
*
|
2007-08-31 |
2009-03-12 |
The Board Of Trustees Operating |
Beta-cyclodextrins as nucleating agents for poly(lactic acid)
|
|
DK3133160T3
(en)
|
2008-10-24 |
2019-04-01 |
Sarepta Therapeutics Inc |
EXON SKIP COMPOSITIONS FOR DMD
|
|
KR101944119B1
(ko)
|
2009-11-13 |
2019-01-30 |
사렙타 쎄러퓨틱스 인코퍼레이티드 |
안티센스 항바이러스 화합물 및 인플루엔자 바이러스 감염을 치료하는 방법
|
|
US9068185B2
(en)
|
2010-03-12 |
2015-06-30 |
Sarepta Therapeutics, Inc. |
Antisense modulation of nuclear hormone receptors
|
|
EP2569431B1
(en)
|
2010-05-13 |
2015-09-23 |
Sarepta Therapeutics, Inc. |
Methods for identifying compounds which modulate interleukins 17 and 23 signaling activity
|
|
JP5925771B2
(ja)
|
2010-06-24 |
2016-05-25 |
トラスティーズ オブ タフツ カレッジ |
ナイアシン模倣体、およびその使用方法
|
|
WO2011163612A1
(en)
|
2010-06-24 |
2011-12-29 |
Trustees Of Tufts College |
Niacin mimetics, and methods of use thereof
|
|
WO2012100142A2
(en)
|
2011-01-20 |
2012-07-26 |
Cornell University |
Treatments for retinal disorders
|
|
AU2012284259A1
(en)
|
2011-07-15 |
2014-03-06 |
Sarepta Therapeutics, Inc. |
Methods and compositions for manipulating translation of protein isoforms from alternative initiation start sites
|
|
HRP20181022T1
(hr)
|
2011-12-08 |
2018-08-24 |
Sarepta Therapeutics, Inc. |
Analozi oligonukleotida koji ciljaju ljudski lmna
|
|
AU2012355619A1
(en)
|
2011-12-23 |
2014-07-17 |
Novartis Ag |
Compounds for inhibiting the interaction of BCL2 with binding partners
|
|
JP2015503515A
(ja)
|
2011-12-23 |
2015-02-02 |
ノバルティス アーゲー |
Bcl2と結合相手の相互作用を阻害するための化合物および組成物
|
|
EA201491260A1
(ru)
|
2011-12-23 |
2014-11-28 |
Новартис Аг |
Соединения и композиции для ингибирования взаимодействия bcl2 с партнерами по связыванию
|
|
BR112014015322A8
(pt)
|
2011-12-23 |
2017-06-13 |
Novartis Ag |
compostos e composições para inibir a interação de bcl2 com parceiros de ligação
|
|
EA201491259A1
(ru)
|
2011-12-23 |
2014-11-28 |
Новартис Аг |
Соединения и композиции для ингибирования взаимодействия bcl2 с партнерами связывания
|
|
DK2861579T5
(da)
|
2012-05-15 |
2022-10-24 |
Novartis Ag |
Benzamidderivater til at hæmme aktiviteten af ABL1, ABL2 og BCR-ABL1
|
|
KR20150020169A
(ko)
|
2012-05-15 |
2015-02-25 |
노파르티스 아게 |
Abl1, abl2 및 bcr-abl1의 활성을 억제하기 위한 벤즈아미드 유도체
|
|
CN104302634B
(zh)
|
2012-05-15 |
2017-02-08 |
诺华股份有限公司 |
用于抑制abl1、abl2和bcr‑abl1的活性的苯甲酰胺衍生物
|
|
PT2900637T
(pt)
|
2012-05-15 |
2017-11-15 |
Novartis Ag |
Derivados de amida de pirimidina, piridina e pirazina substituídos com tiazole ou imidazole e compostos relacionados como inibidores de abl1, abl2 e bcr-abl1 para tratamento do cancro, infecções virais específicas e disturbios do snc específicos
|
|
JP6431480B2
(ja)
|
2012-08-31 |
2018-11-28 |
ザ ジェネラル ホスピタル コーポレイション |
アルツハイマー病の治療および診断のためのビオチン複合体
|
|
FR3000080B1
(fr)
|
2012-12-20 |
2015-01-30 |
Oreal |
Polycondensat de cyclodextrine insoluble dans l'eau ; utilisations comme agent de capture
|
|
FR2999916B1
(fr)
|
2012-12-20 |
2015-01-30 |
Oreal |
Composition permettant la liberation d'agent benefique comprenant un polycondensat de cyclodextrine insoluble dans l'eau et au moins un agent benefique
|
|
EP3885439A1
(en)
|
2012-12-20 |
2021-09-29 |
Sarepta Therapeutics, Inc. |
Improved exon skipping compositions for treating muscular dystrophy
|
|
RS57106B1
(sr)
|
2013-02-19 |
2018-06-29 |
Novartis Ag |
Derivati benzotiofena i njihove kompozicije kao selektivni degraderi estrogenskog receptora
|
|
KR20220061280A
(ko)
|
2013-03-14 |
2022-05-12 |
사렙타 쎄러퓨틱스 인코퍼레이티드 |
근육 이영양증의 치료를 위한 엑손 스키핑 조성물
|
|
EP3633035A1
(en)
|
2013-03-14 |
2020-04-08 |
Sarepta Therapeutics, Inc. |
Exon skipping compositions for treating muscular dystrophy
|
|
BR112015022998A2
(pt)
|
2013-03-15 |
2017-11-14 |
Sarepta Therapeutics Inc |
composições melhoradas para o tratamento de distrofia muscular
|
|
US9227969B2
(en)
|
2013-08-14 |
2016-01-05 |
Novartis Ag |
Compounds and compositions as inhibitors of MEK
|
|
WO2015022663A1
(en)
|
2013-08-14 |
2015-02-19 |
Novartis Ag |
Compounds and compositions as inhibitors of mek
|
|
WO2015022664A1
(en)
|
2013-08-14 |
2015-02-19 |
Novartis Ag |
Compounds and compositions as inhibitors of mek
|
|
WO2015092634A1
(en)
|
2013-12-16 |
2015-06-25 |
Novartis Ag |
1,2,3,4-tetrahydroisoquinoline compounds and compositions as selective estrogen receptor antagonists and degraders
|
|
CN105899491B
(zh)
|
2014-01-17 |
2019-04-02 |
诺华股份有限公司 |
用于抑制shp2活性的1-哒嗪-/三嗪-3-基-哌(-嗪)/啶/吡咯烷衍生物及其组合物
|
|
JO3517B1
(ar)
|
2014-01-17 |
2020-07-05 |
Novartis Ag |
ان-ازاسبيرو الكان حلقي كبديل مركبات اريل-ان مغايرة وتركيبات لتثبيط نشاط shp2
|
|
WO2015107494A1
(en)
|
2014-01-17 |
2015-07-23 |
Novartis Ag |
1 -(triazin-3-yi_/pyridazin-3-yl)-piper(-azine)idine derivatives and compositions thereof for inhibiting the activity of shp2
|
|
MX2017011103A
(es)
|
2015-04-01 |
2018-05-07 |
Int Dioxcide Inc |
Composición estabilizada para el control de olor y la deshidratación potenciada combinados.
|
|
WO2016203406A1
(en)
|
2015-06-19 |
2016-12-22 |
Novartis Ag |
Compounds and compositions for inhibiting the activity of shp2
|
|
EP3310779B1
(en)
|
2015-06-19 |
2019-05-08 |
Novartis AG |
Compounds and compositions for inhibiting the activity of shp2
|
|
EP3310771B1
(en)
|
2015-06-19 |
2020-07-22 |
Novartis AG |
Compounds and compositions for inhibiting the activity of shp2
|
|
EA201890811A1
(ru)
|
2015-09-30 |
2018-09-28 |
Сарепта Терапьютикс, Инк. |
Способы лечения мышечной дистрофии
|
|
EA201892467A1
(ru)
|
2016-04-29 |
2019-05-31 |
Сарепта Терапьютикс, Инк. |
Олигонуклеотидные аналоги, нацеленные на lmna человека
|
|
KR102457146B1
(ko)
|
2016-06-14 |
2022-10-19 |
노파르티스 아게 |
Shp2의 활성을 억제하기 위한 화합물 및 조성물
|
|
TW201811807A
(zh)
|
2016-06-30 |
2018-04-01 |
美商薩羅塔治療公司 |
用於肌肉萎縮症之外顯子跳躍寡聚物
|
|
KR102552428B1
(ko)
|
2016-12-19 |
2023-07-06 |
사렙타 쎄러퓨틱스 인코퍼레이티드 |
근육 이상증에 대한 엑손 스킵핑 올리고머 결합체
|
|
SMT202200440T1
(it)
|
2016-12-19 |
2023-01-13 |
Sarepta Therapeutics Inc |
Coniugati di oligomeri per salto di esone per distrofia muscolare
|
|
EP3554552B1
(en)
|
2016-12-19 |
2022-08-17 |
Sarepta Therapeutics, Inc. |
Exon skipping oligomer conjugates for muscular dystrophy
|
|
JP7679175B2
(ja)
|
2017-04-20 |
2025-05-19 |
エータイアー ファーマ, インコーポレイテッド |
肺の炎症を治療するための組成物および方法
|
|
EA201991450A1
(ru)
|
2017-09-22 |
2019-12-30 |
Сарепта Терапьютикс, Инк. |
Конъюгаты олигомеров для пропуска экзона при мышечной дистрофии
|
|
EP3687577A1
(en)
|
2017-09-28 |
2020-08-05 |
Sarepta Therapeutics, Inc. |
Combination therapies for treating muscular dystrophy
|
|
US20200248178A1
(en)
|
2017-09-28 |
2020-08-06 |
Sarepta Therapeutics, Inc. |
Combination therapies for treating muscular dystrophy
|
|
EP3687519A1
(en)
|
2017-09-28 |
2020-08-05 |
Sarepta Therapeutics, Inc. |
Combination therapies for treating muscular dystrophy
|
|
US10758629B2
(en)
|
2018-05-29 |
2020-09-01 |
Sarepta Therapeutics, Inc. |
Exon skipping oligomer conjugates for muscular dystrophy
|
|
EP3806868A4
(en)
|
2018-06-13 |
2022-06-22 |
Sarepta Therapeutics, Inc. |
EXON SKIPPING OLIGOMERS FOR MUSCULAR DYSTROPHY
|
|
CN108435148A
(zh)
*
|
2018-06-21 |
2018-08-24 |
黄益良 |
一种环糊精改性聚丙烯酰胺污水处理剂及其制备方法
|
|
TW202449155A
(zh)
|
2018-07-27 |
2024-12-16 |
美商薩羅塔治療公司 |
用於肌肉萎縮症之外顯子跳躍寡聚物
|
|
CA3122281A1
(en)
|
2018-12-13 |
2020-06-18 |
Sarepta Therapeutics, Inc. |
Exon skipping oligomer conjugates for muscular dystrophy
|
|
AU2020204925B2
(en)
|
2019-01-03 |
2025-11-20 |
Cyclarity Therapeutics, Inc. |
Cyclodextrin dimers, compositions thereof, and uses thereof
|
|
CN109663578B
(zh)
*
|
2019-02-22 |
2022-02-25 |
安徽大学 |
一种对刚果红超高吸附能力的混合卤化物(MV)[BiI3Cl2]的制备方法及其产品
|
|
CN109806849A
(zh)
*
|
2019-03-25 |
2019-05-28 |
东华大学 |
一种环糊精纳米空心小球及其制备方法
|
|
JP2022526763A
(ja)
|
2019-03-28 |
2022-05-26 |
サレプタ セラピューティクス, インコーポレイテッド |
カシメルセンによる筋ジストロフィーの治療方法
|
|
JP2022528725A
(ja)
|
2019-04-18 |
2022-06-15 |
サレプタ セラピューティクス, インコーポレイテッド |
筋ジストロフィーを治療するための組成物
|
|
WO2020257489A1
(en)
|
2019-06-19 |
2020-12-24 |
Sarepta Therapeutics, Inc. |
Methods for treating muscular dystrophy
|
|
WO2021101606A1
(en)
*
|
2019-11-18 |
2021-05-27 |
Pmidg, Llc |
Compositions for sunscreen compounds and methods thereof
|
|
CN113019344A
(zh)
*
|
2021-03-16 |
2021-06-25 |
大连理工大学 |
一种具有选择性吸附的球形零价铁-环糊精复合材料的制备方法及应用
|
|
CN113372674B
(zh)
*
|
2021-08-13 |
2021-10-19 |
山东三义集团股份有限公司 |
一种氯化聚乙烯用高速挤出加工改性助剂的制备方法
|
|
CN119013401A
(zh)
|
2022-03-17 |
2024-11-22 |
萨勒普塔医疗公司 |
二氨基磷酸酯吗啉代寡聚物缀合物
|
|
WO2024073570A1
(en)
|
2022-09-28 |
2024-04-04 |
Altos Labs, Inc. |
Expression of regeneration factors in aged/senescent cells
|
|
WO2024145608A2
(en)
|
2022-12-30 |
2024-07-04 |
Cornell University |
Acid cyclodextrins for the treatment of lipofuscin buildups and ocular diseases
|
|
CN120441878B
(zh)
*
|
2025-07-09 |
2025-10-17 |
成都飞机工业(集团)有限责任公司 |
一种去除无氰电镀镉溶液中金属杂质的聚合物树脂及其制备方法与使用方法
|